Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04035681 · ClinicalTrials.gov registry record · NA

Problem-Solving Therapy for Depressive Symptoms and Quality of Life in Stroke Survivor-Caregiver Dyads

A NA study, sponsored by Allina Health System.

Completed
Registry status
NA
Development phase
28
Enrollment target

NCT04035681 is a NA study that has completed, run by Allina Health System. The registered enrollment target is 28 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04035681, a NA study, has completed, sponsored by Allina Health System.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

The purpose of this feasibility study is to determine whether it is practical and helpful to provide problem-solving therapy to stroke survivors and their spouses/partners (caregivers) together. It will also compare the experiences of participants who receive problem-solving therapy to those who receive stroke-related health education. Many stroke survivors and caregivers report feeling sad or blue at some point after the stroke. These feelings can impact quality of life. Encountering problems is a part of daily life. These problems can be big or small, but sometimes they can pile up and feel overwhelming, contributing to feelings of sadness. Problem-solving therapy is a tool that teaches structured ways to address current problems or challenges in your life. Participants who are assigned to receive problem-solving therapy will work with a research team member for six, one-hour sessions. During each session, participants will identify a problem (big or small) and create a plan to work on that problem. Participants who are assigned to receive stroke-related health education will work with a research team member who will teach them about various topics related to stroke over six, one-hour sessions. Each session will cover information about a different topic related to stroke. Outcomes data will be collected at approximately 4 weeks, 8 weeks, and 13 weeks from baseline.

Interventions

  • BEHAVIORAL Problem-Solving Therapy
  • OTHER Stroke-Related Health Education

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2019-06-10
Est. Completion 2020-07-22
Phase NA

Sponsor

Allina Health System

32 total trials

What the Registry Record Tells You About NCT04035681

The ClinicalTrials.gov registry entry for NCT04035681 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allina Health System, which has 32 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Problem-Solving Therapy is the first listed.

NCT04035681 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04035681 about?

NCT04035681 is a clinical study titled "Problem-Solving Therapy for Depressive Symptoms and Quality of Life in Stroke Survivor-Caregiver Dyads". The purpose of this feasibility study is to determine whether it is practical and helpful to provide problem-solving therapy to stroke survivors and their spouses/partners (caregivers) together. It will also compare the experiences of participants who receive problem-solving therapy to those who rec...

What is the current status of trial NCT04035681?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2019-06-10. Estimated completion is 2020-07-22.

What interventions are being tested in trial NCT04035681?

The interventions under investigation include: Problem-Solving Therapy (BEHAVIORAL), Stroke-Related Health Education (OTHER).

Who is sponsoring clinical trial NCT04035681?

This trial is sponsored by Allina Health System, which has 32 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.